Type 2 Diabetes Mellitus and Chronic Kidney Disease

NCT ID: NCT04971252

Last Updated: 2024-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-07-07

Study Completion Date

2023-07-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the effect of co existance of diabetes mellitus and chronic kidney disease on basic coagulation profile in comparison with diabetic patients with normal kidney function and non diabetic patients with chronic kidney disease

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We will study impact of type 2 diabetes mellitus on basic coagulation profile and platelet indices among patients with chronic kidney disease

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Disorder Associated With Type II Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Co existance of diabetes mellitus and chronic kidney disease

Study basic coagulation profile and platelet indices among those patients with combined diabetes mellitus and chronic kidney disease

Hematologic tests for patients with diabetes mellitus and chronic kidney disease

Intervention Type DIAGNOSTIC_TEST

Study basic coagulation profile and platelet indices among diabetic patients with chronic kidney disease

Diabetes mellitus without chronic kidney disease

Study basic coagulation profile and platelet indices among those patients with diabetes mellitus only

Hematologic tests for patients with diabetes mellitus and chronic kidney disease

Intervention Type DIAGNOSTIC_TEST

Study basic coagulation profile and platelet indices among diabetic patients with chronic kidney disease

Chronic kidney disease without diabetes mellitus

Study basic coagulation profile and platelet indices among those patients with chronic kidney disease without diabetes mellitus

Hematologic tests for patients with diabetes mellitus and chronic kidney disease

Intervention Type DIAGNOSTIC_TEST

Study basic coagulation profile and platelet indices among diabetic patients with chronic kidney disease

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hematologic tests for patients with diabetes mellitus and chronic kidney disease

Study basic coagulation profile and platelet indices among diabetic patients with chronic kidney disease

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with diabetes mellitus with and without chronic kidney disease Patients with chronic kidney disease without diabetes mellitus

Exclusion Criteria

* any situation influence on basic coagulation profile and platelet indices other than diabetes mellitus and chronic kidney disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Khalaf Mohamed

Assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sohag University

Sohag, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Gundogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, Altunbas H, Gokce C, Kalkan A, Yazici C. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Metab Syndr Relat Disord. 2009 Oct;7(5):427-34. doi: 10.1089/met.2008.0068.

Reference Type BACKGROUND
PMID: 19754305 (View on PubMed)

Odegaard AO, Jacobs DR Jr, Sanchez OA, Goff DC Jr, Reiner AP, Gross MD. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016 Mar 24;15:51. doi: 10.1186/s12933-016-0369-6.

Reference Type BACKGROUND
PMID: 27013319 (View on PubMed)

Ulutas KT, Dokuyucu R, Sefil F, Yengil E, Sumbul AT, Rizaoglu H, Ustun I, Yula E, Sabuncu T, Gokce C. Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: a marker for atherosclerosis? Int J Clin Exp Med. 2014 Apr 15;7(4):955-61. eCollection 2014.

Reference Type BACKGROUND
PMID: 24955167 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-21-07-24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.